Advertisement

Cytotoxycity and antiplasmodial activity of phenolic derivatives from Albizia zygia (DC.) J.F. Macbr. (Mimosaceae)

  • Romeol Romain Koagne
  • Frederick Annang
  • Bastien Cautain
  • Jesús Martín
  • Guiomar Pérez-Moreno
  • Gabin Thierry M. Bitchagno
  • Dolores González-Pacanowska
  • Francisca Vicente
  • Ingrid Konga SimoEmail author
  • Fernando Reyes
  • Pierre TaneEmail author
Open Access
Research article
Part of the following topical collections:
  1. Basic Research

Abstract

Background

The proliferation and resistance of microorganisms area serious threat against humankind and the search for new therapeutics is needed. The present report describes the antiplasmodial and anticancer activities of samples isolated from the methanol extract of Albizia zygia (Mimosaseae).

Material

The plant extract was prepared by maceration in methanol. Standard chromatographic, HPLC and spectroscopic methods were used to isolate and identify six compounds (1–6). The acetylated derivatives (7–10) were prepared by modifying 2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid and quercetin 3-O-α-L-rhamnopyranoside, previously isolated from A. zygia (Mimosaceae). A two-fold serial micro-dilution method was used to determine the IC50s against five tumor cell lines and Plasmodium falciparum.

Results

In general, compounds showed moderate activity against the human pancreatic carcinoma cell line MiaPaca-2 (10 < IC50 < 20 μM) and weak activity against other tumor cell lines such as lung (A-549), hepatocarcinoma (HepG2) and human breast adenocarcinoma (MCF-7and A2058) (IC50 > 20 μM). Additionally, the two semi-synthetic derivatives of quercetin 3-O-α-L-rhamnopyranoside exhibited significant activity against P. falciparum with IC50 of 7.47 ± 0.25 μM for compound 9 and 6.77 ± 0.25 μM for compound 10, higher than that of their natural precursor (IC50 25.1 ± 0.25 μM).

Conclusion

The results of this study clearly suggest that, the appropriate introduction of acetyl groups into some flavonoids could lead to more useful derivatives for the development of an antiplasmodial agent.

Keywords

Phenolic compounds Anticancer activity Plasmodium falciparum Albizia zygia 

Abbreviations

ABC

ATP-binding cassette

BCRP

Breast cancer resistance protein

D.R.

Resistance

DMSO

Dimethylsulfoxide

EGFR

Epidermal growth factor receptor

FITC

Flouresceinisothiocynate

H2DCFH-DA

2′,7′-dichlorodihydrofluoresceine diacetate

H2O2

Hydrogen peroxide

JC-1

5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide

IC50

50% inhibitory concentration

MDR

Multidrug resistance

MMP

Mitochondrial membrane potential

M-PERs

Mammalian Protein Extraction Reagent

PBS

Phosphate buffer saline

PARP-1

Poly (ADP-ribose) polymerase 1

P-gp

P-glycoprotein

PI

Propidium iodide

RIP-3

Receptor-interacting protein 3

ROS

Reactive oxygen species

RT

Room temperature

SDS–PAGE

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis

Background

Albizia is a large genus belonging to the Mimosaceae plant family. It comprises at least 150 species mostly trees and shrubs native to tropical and subtropical regions of Asia and Africa [1]. In traditional medicine, the roots bark of Albizia zygia are used against cough, while its stem bark is used as a purgative, antiseptic, aphrodisiac, to treat gastritis, fever, conjunctivitis, as well as to fight worms and overcome female sterility [2, 3]. The methanol extract of its stem bark has been reported to exhibit strong activity against P. falciparum K1 strain and Trypanosoma brucei rhodesiense [4, 5, 6]. The genus Albizia is phytochemically known as a source of saponin compounds with a large number of sugar moieties [3, 7, 8]. Despite this predisposition to produce saponins, previous works have also reported flavonoids, alkaloids and tannins [9, 10, 11]. Thus, we carried out and reported herein the fractionation and purification of methanol extract of A. zygia followed by the acetylation of the two most abundant isolated compounds obtained, 2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid and quercetin 3-O-α-L-rhamnopyranoside. The cytotoxic and antiplasmodial activities of compounds are also reported.

Methods

General experimental procedures

Column chromatography were proceeded with Silica gel 60 F254 (70–230; Merck; Darmstadt, Germany). TLC developed on precoated silica gel Kieselgel 60 F254 plates (0.25 mm thick) and compounds were detected by spraying with 50% H2SO4 on it before being heated at 100 °C. Semi-preparative and preparative HPLC was performed using a Gilson FX-281322H2 High Performance Liquid Chromatography coupled to a DAD detector and an automatic fraction collector. ASunfire C18 column (10 μm, 10 × 250 mm) and (5 μm, 10 × 150 mm) were used in these separations. (+)-ESITOF-MS was performed as previously described [12]. We recorded NMR spectra on a Bruker Avance III spectrometer, equipped with a 1.7 mm TCI microcryoprobe, (500.0 and 125.0 MHz for 1H and 13C NMR, respectively). The chemical shifts are given in part per million (ppm) using the signal of the residual solvent as internal reference. The coupling constant (J) are in Hertz.

Plant material

The leaves of Albizia zygia (DC) J.F. Macbr were collected on the slopes of the cliff of Santchou, West Region of Cameroon in March 2013. It is a public and well known wild. Thus, access and collection of samples do not require any permission according to the legislation of Cameroon. These leaves were identified at the National Herbarium of Cameroun (NHC) by comparison to a voucher specimen under the number N° 43,969 HNC.

Extraction and isolation

Dried leaves of A. zygia were ground to a fine powder (0.77 Kg) and macerated with methanol (5 L) for 24 h (repeated 3 times) at room temperature. After filtration and removal of the solvent in vacuo, a crude extract of 42.0 g was obtained. The extract was subjected to silica gel column chromatography (CC) eluting with gradient of n-hexane-EtOAc and then EtOAc-MeOH to afford four major fractions (A-D). Fraction A was not further investigated, it contains mostly fatty material and fraction B (3.2 g) was separated by column chromatography over silica gel with a (5–30%) of n-hexane-EtOAc to give quercetin (6) (27.0 mg). Fraction C (12.6 g) was separated by column chromatography over silica gel using gradient (5–50%) of CH2Cl2-MeOH to give a mixture of compounds 2 and 3 (97.3 mg). Fraction D (20.8 g) was subjected to silica gel column chromatography eluted with gradient (5–40%) of EtOAc-MeOH to give phaseoloidin (1) (335.6 mg) and a mixture of 4 and 5 (9.8 mg). Further purification of the two above mentioned mixtures by semi-preparative HPLC eluted with a gradient of acetonitrile-water from 5 to 100% as mobile phase, afforded quercetin 3-O-α-L-rhamnopyranoside (2) (44.4 mg) and kampherol 3-O-α-L-rhamnopyranoside (3) (13.7 mg) from the first mixture, and quercetin 3,4′-di-O-α-L-rhamnopyranoside (4) (1.6 mg) and kaempferol 3,4′-di-O-α-L-rhamnopyranoside (5) (1.1 mg) from the second one.

Semi-synthetic compounds

Acetylation of 2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid (1): 2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid (10.0 mg, 3.03 10− 5 mol) was dissolved in 1 mL of pyridine, 0.25 mL of acetic anhydride (0.026 mol) were added, and the mixture was left to stand for 24 h. Extraction with CH2Cl2 and semi-preparative HPLC purification (ACN-H2O, 5–100) gave two new derivatives: compounds 7 (2.2 mg, yield:15%) and 8 (1.9 mg, yield: 11%).

2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid (1): white powder;1H NMR (500 MHz, DMSO-d6): δH 6.60 (d, J = 2.6 Hz, H-3), 6.57 (dd, J = 2.6 and 8.7 Hz, H-5), 6.95 (d, J = 8.7 Hz, H-6), 3.58 (s, H-7), 4.53 (d, J = 6.7 Hz, H-1′), 3.51 (d, J = 16.5 Hz, H-2′), 3.67 (d, J = 11.9 Hz, H-3′), 3.61 (d, J = 15.9 Hz, H-4′), 3.13 (m, H-5′), 3.45 (m, H-6′); 13C NMR (125 MHz, DMSO-d6): δC 173.7 (C-8), 35.6 (C-7), 117.6 (C-4), 117.6 (C-5), 118.0 (C-3), 126.6 (C-1), 152.7 (C-2), 103.3 (C-1′), 73.9 (C-2′), 77.0 (C-3 ‘), 70.3 (C-4’), 77.5 (C-5 ‘), 61.5 (C-6’); (+)-HRESI-MS: m/z 348.1288 (calcd. For C14H22O9N, 348.1289).

Compound 7: colorless oil; 1H NMR (500 MHz, MeOD):δH 7.01(d, J = 2.6 Hz, H-3), 6.65 (dd, J = 8.6 and 2.6 Hz, H-5), 6.69 (d, J = 2.6 Hz, H-6), 3.62 (d, J = 16.4 Hz, H-7α), 3.46 (d, J = 16.4 Hz, H-7β), 5.35 (t, J = 7.4 Hz, H-1′), 4.33 (dd, J = 5.0 and 12.2 Hz, H-2′), 5.13 (m, H-3′), 4.18 (dd, J = 2.6 and 12.3 Hz, H-4′), 3.99 (m, H-5′), 5.17 (m, H-6’α), 5.11 (m, H-6’β), 2.10 (s, 3H), 2.08 (s, 3H), 2.05 (s, 3H), 2.01 (s, 3H); HRESI-MS (+): m/z 516.1708 (calcd for C22H30NO13, 516.1712).

Compound 8: colorless oil; 1H NMR (500 MHz, MeOD): δH 7.01 (d, J = 2.4 Hz, H-3), 6.99 (dd, J = 8.9 and 2.4 Hz, H-5), 7.17 (d, J = 8.9 Hz, H-6), 3.68 (d, J = 15.0 Hz, H-7), 3.48 (d, J = 15.9 Hz, H-7), 5.29 (d, J = 7.3 Hz, H-1′), 4.34 (dd, J = 5.5 and 12.3 Hz, H-2′), 5.21 (J = 2.1 and 7.5 Hz, H-3′), 4.17 (dd, J = 2.4 and 12.3 Hz, H-4′), 4.08 (m, H-5′), 5.16 (m, H-6’α), 5.12(m, H-6’β), 2.09 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H), 2.01(s, 3H), 2.26 (s, 3H); HRESI-MS (+): m/z 558.1814 (calcd for C24H32NO14, 558.1817).

Acetylation of quercetin 3-O-α-L-rhamnyranoside (2) Quercetin 3-O-α-L-rhamnyranoside (22.0 mg, 4.91 10− 5 mol) was dissolved in 2.5 mL of pyridine, and 0.75 mL of acetic anhydride (0.0079 mol) were added, the mixture was left to stand for 24 h. Extraction with CH2Cl2 and semi-preparative HPLC purification gave two new derivatives: compounds 9 (7.6 mg, yield 18%) and 10 (2.8 mg, yield 6%).

Quercetin 3-O-α-L-rhamnyranoside (2): yellow powder; 1H NMR (500 MHz, MeOD): δH 6.32 (s, H-6), 6.17 (s, H-8), 7.35 (s, H-2′), 7.29 (d, J = 7.9 Hz, H-6′), 6.92 (d, J = 7.9 Hz, H-5′), 5.36 (s, H-1″), 3.79 (d, J = 8.8 Hz, H-2″), 3.44 (m, H-3″), 3.37 (m, H-4″), 4.26 (m, H-5″), 0.91 (d, J = 6.1 Hz, H-6″); 13C NMR (125 MHz, MeOD): δC 134.8 (C-3), 178.1 (C-4), 156.9 (C-5), 93.5 (C-6), 164.7 (C-7), 98.6 (C-8), 157.9 (C-9), 104.3 (C-10), 121.6 (C-1′), 115.7 (C-2′), 144.9 (C-3′), 148.4 (C-4′), 115.1 (C-5′), 121.7 (C-6′), 102.2 (C-1″), 70.8 (C-2″), 70.6 (C-3″), 71.9 (C-4″), 70.5 (C-5″), 16.3 (C-6″); (+)-HRESI-MS: m/z 449.1076 (calcd. 449.1078 for C21H21O11).

Compound 9: yellow oil; 1H NMR (500 MHz, MeOD): δH 6.23 (d, J = 1.9 Hz, H-6), 6.41 (d, J = 1.9 Hz, H-8), 7.35 (d, J = 2.2 Hz, H-2′), 6.96 (d, J = 7.1 Hz, H-5′), 7.33 (dd, J = 2.2 and 7.1 Hz, H-6′), 5.60 (d, J = 1.6 Hz, H-1″), 5.63 (d, J = 3.3 Hz, H-2″), 5.28 (d, J = 3.3 Hz, H-3″), 4.88 (m, H-4″), 3.41 (m, H-5″), 0.87 (d, J = 6.3 Hz, H-6″), 2.13 (s, 11-Me), 2.02 (s, 13-Me), 1.99 (s, 15-Me); 13C NMR (125 MHz, MeOD): δC 133.1 (C-3), 161.9 (C-5), 93.3 (C-6), 164.1 (C-7), 98.6 (C-8), 157.2 (C-9), 104.5 (C-10), 120.9 (C-1′), 121.4 (C-2′), 145.4 (C-3′), 148.6 (C-4′), 114.9 (C-5′), 115.2 (C-6′), 97.8 (C-1″), 68.7 (C-2″), 69.2 (C-3″), 70.0 (C-4″), 68.1 (C-5″), 16.1 (C-6″), 170.0 (C-11), 18.9 (C-12), 170.6 (C-13), 19.2 (C-14), 170.3 (C-15), 19.0 (C-16); (+)-HRESI-MS: m/z 575.1388 (calcd. 575.1395 for C27H27O14).

Compound 10: yellow oil; 1H NMR (500 MHz, MeOD): δH 6.56 (d, J = 2.3 Hz, H-6), 6.82 (d, J = 2.5 Hz, H-8), 7.33 (d, J = 2.1 Hz, H-2′), 6.96 (d, J = 7.7 Hz, H-5′), 7.32 (dd, J = 2.0 and 7.1 Hz, H-6′), 5.46 (d, J = 1.3 Hz, H-1″), 5.29 (d, J = 3.6 Hz, H-2″), 5.27 (d, J = 3.6 Hz, H-3″), 4.77 (m, H-4″), 3.37 (m, H-5″), 0.87 (d, J = 6.1 Hz, H-6″), 2.13 (s, 11-Me), 2.02 (s, 13-Me), 1.98 (s, 15-Me), 2.37 (s, 17-Me); 13C NMR (125 MHz, MeOD): δC 133.1 (C-3), 161.9 (C-5), 108.7 (C-6), 163.8 (C-7), 100.3 (C-8), 157.2 (C-9), 104.5 (C-10), 120.9 (C-1′), 115.1 (C-2′), 145.4 (C-3′), 148.6 (C-4′), 114.9 (C-5′), 121.4 (C-6′), 97.9 (C-1″), 68.7 (C-2″), 69.2 (C-3″), 70.0 (C-4″), 68.1 (C-5″), 15.9 (C-6″), 170.0 (C-11), 19.1 (C-12), 170.4 (C-13), 19.0 (C-14), 170.3 (C-15), 19.0 (C-16), 169.9 (C-17), 19.5 (C-18); (+)-HRESI-MS: m/z 617.1497 (calcd for C29H29O15, 617.1501).

P. falciparum 3D7 lactate dehydrogenase assay: Parasites of the P. falciparum strain 3D7 were grown in fresh group 0 positive human erythrocytes, obtained from the Centro Regional de Transfusion Sanguınea-SAS (Granada, Spain). This assay was performed in duplicate for each compound using a sixteen (16) point dose response curve (½ serial dilutions) with concentrations starting from 50 μM until 1.5 nM to determine the IC50s of the compounds. Adding 25 μL of P. falciparum 3D7 parasite culture (per well) containing parasitized red blood cells at 0.25% parasitaemia and 2% haematocrit in RPMI-1640, 5% Albumax II, 2% D-sucrose 0.3% glutamine and 150 μM hypoxanthine and incubated at 37 °C for 72 h with 5% CO2, 5% O2 and 95% N2. For negative and positive growth controls, 10 μM chloroquine and complete parasite growth medium were respectively used. The final readouts of the assay was done by measuring the absorbance of the reactions at 650 nm in an Envision plate reader (Perkin Elmer, USA) and the results analysed by Genedata software (GenedataAG, Basel, Switzerland), parasite growth was measured by LDH assay as previously described [12, 13].

Anticancer assays: Five tumor cell lines (MiaPaca-2 (CRL-1420), a carcinoma pancreatic from 65 years adult; Hep G2 (HB-80665), a perpetual cell line which was derived from the liver tissue of a 15-year-old Caucasian American male with a well-differentiated hepatocellular carcinoma; A549 (CCL-185), a carcinoma lung from 58-year-old Caucasian made; A2058 (CRL-11147), Human skin melanoma from a 43 years Caucasian adult derived from lymph node and MCF-7 (HTB-22), a breast adenocarcinoma from 69 years woman) were obtained from ATCC. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide) colorimetric assay, which measures mitochondrial metabolic activity, was employed to estimate the amount of living cells. According to the huge amount of celles to be plated, SelecT (TAP Biosystems, Royston, UK), a cell culture robotic system was used to process ten thousand cells per well (for 72 h assay). Cells were seeded at a concentration of 1× 104 cells/well in 200 μl culture medium and incubated at 37 °C in 5% CO2. After 24 h, the automated liquid-handling system Biomek FX (Beckman Coulter, Pasadena, CA, USA) was used to replace the medium with a final volume of 200 μL and 1 μL of compound (dilution 1/200) and to add controls to the plates and which were then be incubated for 72 h. The test compounds were examined in triplicate with serial two-fold dilutions. After incubation, MTT solution was prepared at 5 mg/mL in PBS 1X and then diluted at 0.5 mg/mL in MEM without phenol red. The sample solution in wells was removed and 100 μL of MTT dye was added to each well. The plates were gently shaken and incubated for 3 h at 37 °C in 5% CO2 incubator. The supernatant was removed and 100 μL of DMSO 100% was added. The plates were gently shaken to solubilize theoriginated formazan and absorbance at 570 nm was read in a Victor2 Wallac spectrofluorometer (PerkinElmer, Waltham, MA, USA). IC50 values were calculated as the concentration that decreases 50% of the cell viability using Genedata Screener software (Genedata AG, Basel, Switzerland). Curve fitting followed the Smart Fit strategy with Hill model selection.

Results

The methanol extract of the leaves of A. zygia was purified over silica gel, Sephadex LH-20 column chromatography and HPLC to afford six phenolic compounds (16); two of them were subjected to acetylation to give four new semi-synthetic compounds. The structures of the isolated compounds were determined by spectroscopic and spectrometric data and comparison with those of similar reported compounds. Both, naturally occurring and semi-synthetically prepared metabolites were screened for their antiplasmodial and cytotoxic properties.

Phytochemical analysis

The natural occurring compounds were already described in the literature, phaseoloidin (1), quercetin 3-O-α-L-rhamnopyranoside (2), kaempferol 3-O-α-L-rhamnopyranoside (3), quercetin 3,4′-di-O-α-L-rhamnopyranoside (4), kaempferol 3,4′-di-O-α-L-rhamnopyranoside (5) and quercetine (6) (Fig. 1) [14, 15, 16]. Phaseoloidin was previously reported from the Nicotiana attenuate trichomes [14] and this is the first report of its occurrence in the genus Albizia. On the contrary, all the isolated flavonoids have been previously obtained from other species of Albizia genus.
Fig. 1

Chemical structure of compounds isolated from A. zygia1–6

Chemical transformation

The starting materials, 2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid and quercetin 3-O-α-L-rhamnopyranoside, isolated from the leaves of A. zygia, were subjected to acetylation by reacting with acetic anhydride in pyridine, followed by semi-preparative HPLC purification. The structures of the semi-synthetic derivatives 710 (Fig. 2) were determined on the basis of their NMR and HRESI-MS data and comparison with those of compounds 1 and 2.
Fig. 2

Chemical structure of new semi synthetic compounds 710

Compound 7 was obtained as colorless oil with a molecular formula of C22H26O13 deduced from its (+)-ESI-TOF-MS which showed an ammonium adduct [M + NH4]+ at m/z 516.1708 (calcd. 516.1712 for C22H30NO13). Its structure was deduced by comparing its 1H NMR data with those of 2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid (1). Indeed, the 1H NMR spectrum of 7 exhibited signals of three aromatic protons at δH 7.01 (d, 1H, J = 8.6 Hz, H-6), 6.69 (d, 1H, J = 2.6 Hz, H-3) and 6.65 (dd, 1H, J = 8.6 and 2.6 Hz, H-4) and two methylene protons at δH 3.62 (d, 1H, J = 16.4 Hz, H-7α) and 3.46 (d, 1H, J = 16.4 Hz, H-7β). In addition to these signals common to 1, the spectrum displayed signals of four methyl groups at δH2.10 (s, 3H), 2.08 (s, 3H), 2.04 (s, 3H) and 2.01 (s, 3H), corresponding to methyl protons of four aliphatic acetyl groups, indicating the acetylation of the four free hydroxyl groups of the glucose moiety of 1. Aliphatic hydroxyl groups, like those of the sugar moiety, are more reactive than those of the phenol groups [17, 18].

Compound 8 was obtained as colorless oil. A molecular formula of C24H28O14 was deduced from its (+)-ESI-TOF-MS which showed an ammonium adduct [M + NH4]+ at m/z 558.1814 (calcd. 558.1817 for C24H32NO14). As for compounds 1 and 7, the 1H NMR spectrum displayed three aromatic protons at δH 7.17 (d, 1H, J = 8.9 Hz, H-6), 7.01 (d, 1H, J = 2.4 Hz, H-3) and 6.69 (dd, 1H, J = 8.9 and 2.4 Hz, H-5) and a methylene group at δH 3.68 (d, 1H, J = 15.0 Hz, H-7α) and 3.48 (d, 1H, J = 15.0 Hz, H-7β). Four methyl groups were also observed at δH 2.09 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H) and 2.01 (s, 3H) corresponding to the acetylated sugar moiety. Additionally, the spectrum showed the signal of a fifth methyl group attributable to the aromatic acetyl at δH 2.26 (s, 3H) confirming the peracetylation of compound 1.

Compound 9 was obtained as yellow oil. The molecular formula C27H26O14 was deduced from its positive mode (+)-ESI-TOF-MS, which showed a pseudo-molecular ion [M + H]+ at m/z 575.1388 (calcd. 575.1395 for C27H27O14). Its structure was deduced from that of quercetin 3-O-α-L-rhamnoside (2). In fact, the 1H NMR spectrum of 9 exhibited signals characteristics of the B ring at δH 7.35 (d, 1H, J = 2.2 Hz), 7.33 (dd, 1H, J = 2.2 and 7.1 Hz) and 6.96 (d, 1H, J = 7.1 Hz) assignable to H-2′, H-6′ and H-5′, respectively. Additionally, signals of the A ring at δH 6.41 (d, 1H, J = 1.9 Hz) and 6.23 (d, 1H, J = 1.9 Hz), assigned to H-8 and H-6, respectively, were also observed. The anomeric proton at δH 5.60 (d, 1H, J = 1.6 Hz, H-1″), the signals of methine groups at δH 5.30 (d, 1H, J = 3.3 Hz, H-2″), 5.28 (d, 1H, J = 3.3 Hz, H-3″), 3.43 (m, 1H, H-4″) and 3.41 (m, 1H, H-5″) and the methyl group at 0.87 (d, 3H, J = 6.3 Hz, H-6″) recalled those signals of a rhamnose moiety in the structure of 9. In addition to these signals common to compound 2, the spectrum also showed three methyl groups at δH 1.99 (s, 3H), 2.02 (s, 3H) and 2.13 (s, 3H) corresponding to three acetyl groups. The HMBC spectrum revealed that these methyls were located on the sugar moiety.

Compound 10 was obtained as yellow amorphous powder. Its molecular formula, C29H28O15, was assigned from its positive mode (+)-ESI-TOF-MS, which showed a pseudo-molecular ion [M + H]+ at m/z 617.1493 (calcd. 617.1501 for C29H29O15). The 1H NMR spectrum of compound 10 displayed signal patterns similar to those of compounds 2 and 9, including the three protons of B ring at δH 7.33 (d, 1H, J = 2.1 Hz, H-2′), 7.32 (dd, 1H, J = 2.1 and 8.7 Hz, H-6′) and 6.96 (d, 1H, J = 8.7 Hz, H-5′) and the two protons of A ring at δH 6.82 (d, 1H, J = 2.5 Hz, H-8) and 6.56 (d, 1H, J = 2.5 Hz, H-6), assignable to the flavonoid part of the molecule. In addition to signals corresponding to the three acetyl groups already observed in compound 9 at δH 1.98 (s, 3H), 2.02 (s, 3H) and 2.13 (s, 3H), the spectrum showed an additional methyl group attributable to an aromatic acetyl group at δH 2.37 (s, 3H) linked to C-7. One can noticed the deshielding of signals from carbons C-8 and C-6 compared to their homolog compounds 9 and 2. The fact that only the hydroxyl at C-7 was acetylated can be explained also by the chelation observed between the hydroxyl group at C-5 and the carbonyl at C-4 and between the two hydroxyl groups at C-3′ and C-4′, which will make the latter hydroxyl groups less reactive than the OH-7. Appropriate NMR and MS spectra are provide as supplementary material (Additional file 1: fig. S1 - fig. S14).

Antiplasmodial activity

The natural compounds isolated from the leaves of A. zygia as well as their semi-synthetic derivatives were tested against Plasmodium falciparum (Table 1) using a microdilution method in liquid medium as previously described [13]. The two semi-synthetic derivatives of quercetin 3-O-α-L-rhamnopyranoside exhibited significant activity against P. falciparum with IC50 values of 7.5 ± 0.25 μM for compound 9 and 6.8 ± 0.25 μM for compound 10. However, the natural precursor of these two semi-synthetic derivatives showed a weak activity (IC50 25.1 ± 0.25 μM), similar to that of kaempferol 3-O-α-L-rhamnopyranoside (3) (IC50 19.0 ± 0.25 μM). The natural precursor 2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid (1) and its semi-synthetic derivatives 7 and 8 together with quercetin 3,4′-di-O-α-L-rhamnopyranoside (4) and kaempferol 3,4′-di-O-α-L-rhamnopyranoside (5) did not show any activity against P. falciparum (IC50 > 100 μM). Chloroquine gave an IC50 of 2.96 ± 0.25 nM when tested under the same conditions.
Table 1

IC50 of natural and semi-synthetics compounds from A. zygia against P. falciparum

 

Compounds IC50 (SI) in μM

1

2

3

4

5

7

8

9

10

Chloroquine

P. falciparum

> 100

25.1 ± 0.25

19.0 ± 0.25

> 100

> 100

> 100

> 100

7.5 ± 0.25

6.8 ± 0.25

0.00296

(nd)

(3.49)

(1.22)

(nd)

(nd)

(nd)

(nd)

(3.03)

(9.57)

SI = IC50 HepG2 cell/IC50 P. falciparum

Anticancer activity

The natural compounds 15 as well as the semi-synthetic derivatives 710, were screened for cytotoxic effects against five human tumor cell lines namely MiaPaca-2 (pancreas), A-549 (lung), HepG2 (liver), MCF-7 (breast) and A2058 (breast) (Table 2). The compounds showed moderate activity against MiaPaca-2 with IC50 values of 17.3 ± 0.25, 16.8 ± 0.25, 10.0 ± 0.25, 18.5 ± 0.25 and 17.4 ± 0.25 μM for quercetin 3,4′-di-O-α-L-rhamnopyranoside (4), kaempferol 3,4′-di-O-α-L-rhamnopyranoside (5), compounds 7, 8 and 9, respectively. Compound 9 also showed moderate activity against MCF-7 (IC50 10.8 ± 0.25 μM) and A-2058 (IC50 12.2 ± 0.25 μM) as well as quercetin 3,4′-di-O-α-L-rhamnopyranoside (4) against MCF-7 IC50 (17.3 ± 0.25 μM) and HepG2 (IC50 17.3 ± 0.25 μM). According to the screening program of the National Cancer Institute, USA, a compound is generally considered to have in vitro cytotoxic activity if the IC50 value following incubation between 48 and 72 h, is less than 4 μg/mL or 10 μM [19]. In the present report, IC50 values below or around this threshold (10 μM) were obtained with compound 9 against MCF-7 (IC50 10.8 μM) and compound 7 against Miapaca-2 (IC50 10.0 μM).
Table 2

Cytotoxycity of natural and semi-synthetics compounds from A. zygia

Cell lines

Compounds IC50 (μM)

1

2

3

4

5

7

8

9

10

Doxorubicin

MCF-7

42.7 ± 0.25

87.5 ± 0.25

46.4 ± 0.25

17.3 ± 0.25

33.7 ± 0.25

37.0 ± 0.25

40.2 ± 0.25

10.8 ± 0.25

64.9 ± 0.25

< 7 × 10−5

A2058

66.7 ± 0.25

87.5 ± 0.25

46.4 ± 0.25

34.6 ± 0.25

33.7 ± 0.25

37.0 ± 0.25

40.2 ± 0.25

12.2 ± 0.25

64.9 ± 0.25

< 7 × 10−5

HepG2

121.2 ± 0.25

87.5 ± 0.25

23.2 ± 0.25

17.3 ± 0.25

16.8 ± 0.25

37.0 ± 0.25

40.2 ± 0.25

22.6 ± 0.25

64.9 ± 0.25

< 7 × 10−5

A-549

121.2 ± 0.25

89.5 ± 0.25

23.2 ± 0.25

34.6 ± 0.25

33.7 ± 0.25

20.1 ± 0.25

20.1 ± 0.25

34.8 ± 0.25

30.5 ± 0.25

< 7 × 10−5

MiaPaca-2

30.3 ± 0.25

87.5 ± 0.25

46.4 ± 0.25

17.3 ± 0.25

16.8 ± 0.25

10.0 ± 0.25

18.5 ± 0.25

17.4 ± 0.25

64.9 ± 0.25

< 7 × 10−5

Discussion

The genus Albizia is so far a source of natural occurring saponins and phenolics [3, 7, 8, 20, 21]. In our study, no saponins were isolated but phenolic compounds were obtained. Chemical composition of plants can differ from one species to another in a group of plants. That can be due to the ecological region where plants are growing. However, this experiment allowed us to confirm once more that Albizia genus continues to be a source of polar compounds as our phenolics were glycosylated. This study aimed also at identifying how acetylation of phenolic compounds can interfere with the antiplasmodial and anticancer activities by comparing IC50 values of precursors to those of semi-synthetic compounds. The results indicate that acetylated derivatives display in general a better activity than their natural precursors.

The antiplasmodial activities of the isolated compounds were 19–100.0 μM and that of acetylated derivatives were 6.8–100.0 μM against Plamodium falciparum strain 3D7. Derivatives 9 (7.5 μM) and 10 (6.8 μM) scored the highest in vitro activity among the compounds tested. Several flavonoids have been reported to exert a moderate antiplasmodial activity in a number of different P. falciparum strains [22, 23, 24]. As a result, we present herein a difference in activity of high hydroxylated flavonoids compared to their acetylated derivatives. This result is interesting insofar that acetylation reaction is easy to achieve in laboratories and flavonoids are very common in plants. Thus, the appropriate introduction of acetyl groups into flavonoids may lead to more useful derivatives for the development of an antiplasmodial agent. In fact, the two acetylated compounds 9 and 10 were over 3 times more active than their natural precursor quercetin 3-O-α-L-rhamnopyranoside (2). However, the absence of activity of phaseolidin (1) and its corresponding derivatives 7 and 8 highlighted that hydroxyl groups are not related to the absence of activity of compound 1 on the protozoal P. falciparum. This is the first report of the antiplasmodial activity of the 2-O-β-D-glucopyranosyl-4-hydroxyphenylacetic acid and quercetin 3-O-α-L-rhamnopyranoside derivatives.

On the other hand and according to the screening program of the National Cancer Institute, USA, a compound is generally considered to have in vitro cytotoxic activity if it exhibits an IC50 ≤ 4.0 mg/mL or 10.0 μM, following its incubation for 48 and 72 h with cancer cells [19]. In the present report, IC50 values equal or around this threshold (10.0 μM) were obtained with compounds 10 (10.8 and 12.2 μM against MCF-7and A2050 respectively) and 7 (10.0 μM against Miapaca-2). In general, as shown in Table 2, the lowest IC50 were obtained with the semisynthetic derivatives (IC50 10.0–64.9 μM) compared to the parent compounds (IC50 16.8–121.2 μM). The current result is in the same line with those previously described in the literature which shows that flavonoids have good anticancer properties [25, 26]. All the compounds isolated and described in this report could be said to be generally non-cytotoxic when compared to the standard drug Doxorubicin which showed an IC50 ≈ 0.0 μM.

However, the theoretical more effectivity and safety of our compounds was calculated. Compound 10 presented a better safety capability (SI = 9.57) compared to its counterpart compound 9 (SI = 3.03). For the others, the toxicity of the drugs was not far enough from the antiplasmodial effects (SI < 3) to guarantee their useness. The toxicity of the flavonoids could be said to be related to the hydroxyl group at C-7.

Conclusion

The objective of this study was to highlight the effect of structure transformation through acetylation of phenolic compounds over anticancer and antiplasmodial activities. The results clearly suggest that, the appropriate introduction of acetyl groups into flavonoids may lead to more useful derivatives for the development of antiplasmodial and anticancer agents.

Notes

Acknowledgments

RRK is grateful to the Organization for Prohibition of Chemical Weapons (OPCW) who granted him a scholarship (N°L/ICA/ICB/201822/17) which allow him to conduct part of his PhD study at the Fundación MEDINA (Spain).

Authors’ contributions

RRK performed the purification of the compounds and the acetylation reactions. BC and FV performed anticancer assays. FA, GPM and DGP performed antiplasmodial assays. JMS analyzed the HRMS and NMR spectra. GTMB identified the vegetal material. RRK, GTMB and IKS performed the structural elucidation of the compounds. RRK, PT, IKS and FR wrote the paper which was revised and approved by all the authors. FR and PT led and coordinated the research. All authors read and aproved the final Manuscript.

Funding

Fundación MEDINA (Spain) provided chemicals and reagents for both chemical and biological studies and the University of Dschang provided also part of chemicals used in this study.

Ethics approval and consent to participate

Not applicable in this section.

Consent for publication

Not applicable in this section.

Competing interests

The authors declare that they have no competing interests.

Supplementary material

12906_2019_2792_MOESM1_ESM.docx (1.8 mb)
Additional file 1. Supplementary Informations, Figure S1 - Figure S14.

References

  1. 1.
    Karuppannan K, Subramanian DP, Venugopal S. Phytopharmacological properties of Albizia species: a review. Int J Pharm Pharm Sci. 2013;5:70–3.Google Scholar
  2. 2.
    Abdalla MA, Laatsch H. Flavonoids from Sudanese Albizia zygia (Leguminosae, subfamily mimosoideae), a plant with antimalarial potency. Afr J Tradit Complement Altern Med. 2012;9:56–8.Google Scholar
  3. 3.
    Note OP, Chabert P, Pegnyem DE, Weniger B, Dubois ML, Lobstei A. Structure elucidation of new acacic acid-type saponins from Albizia coriaria. Magn Reson Chem. 2010;48:829–36.CrossRefGoogle Scholar
  4. 4.
    Kigondu EVM, Rukunga GM, Keriko JM, Tonui WK, Gathirwa JW, Kirira PG, Irungu B, Ingonga JM, NdiegeI O. Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya. J Ethnopharmacol. 2009;123:504–9.CrossRefGoogle Scholar
  5. 5.
    Wanyama PAG, Kiremire BT, Murumu JES, Kamoga O. Textile dyeing and phytochemical characterization of crude plant extracts derived from selected dye-yielding plants in Uganda. Int J Nat Prod Res. 2011;1:26–31.Google Scholar
  6. 6.
    Lenta BN, Vonthron-Sénécheau C, Soh RF, Tantangmo F, Ngouela S, Kaiser M, Tsamo E, Anton R, Weniger B. In vitro antiprotozoal activities and cytotoxicity of some selected Cameroonian medicinal plants. J Ethnopharmacol. 2007;111:8–12.CrossRefGoogle Scholar
  7. 7.
    Cheng ZQ, Yang D, Ma QY, Yi XH, Zhang NL. Triterpenoid saponins from Albizia mollis. Bul Korean Chem. 2011;32:1403–9.CrossRefGoogle Scholar
  8. 8.
    Singab AN, Bahgat D, Al-Sayed E, Eldahshan O. Saponins from genus Albizia: phytochemical and biological review. J Med Arom. 2015;10:4172–2167.Google Scholar
  9. 9.
    Gupta RS, Chaudhary R, Yadav RK, Verma SK, Dobhal MP. Effect of saponins of Albizia lebbeck (L.) Benth bark on the reproductive system of male albino rats. J Ethnopharmacol. 2005;96:31–6.CrossRefGoogle Scholar
  10. 10.
    Abdel-Kader M, Hoch J, Berger JM, Evans R, Miller JS. Two bioactive saponins from Albizia subdimidiata from the Suriname rainforest. J Nat Prod. 2000;64:536–9.CrossRefGoogle Scholar
  11. 11.
    Debella A, Haslinger E, Schmid MG, Bucar F, Michl G. Triterpenoid saponins and sapogenin lactones from Albizia gummifera. Phytochemistry. 2001;53:885–92.CrossRefGoogle Scholar
  12. 12.
    Martín J, Crespo G, González-Menéndez V, Pérez-Moreno G, Sánchez-Carrasco P, Pérez-Victoria I, Ruiz-Pérez LM, González-Packanowska D, Vicente F, Genilloud O, Bills GF, Reyes F. MDN-0104, an antiplasmodial betaine lipidfrom Heterosporachenopodii. J NatProd. 2014;77:2118–23.Google Scholar
  13. 13.
    Pérez-Moreno G, Cantizani J, Sánchez-Carrasco P, Ruiz-Pérez LM, Martín J, El Aouad N, Pérez-Victoria I, Tormo JR, González-Menendez V, González I, de Pedro N, Reyes F, Genilloud O, Vicente F, González-Pacanowska D. Discovery of new compounds active against Plasmodium falciparumby high throughput screening of microbial natural products. PLoSOne. 2016;11:e0145812.CrossRefGoogle Scholar
  14. 14.
    Weinhold A, Wenzler M, Schneider B, Baldwin IT. Phaseoloidin, a homogentisic acid glucoside from Nicotiana attenuata trichomes, contributes to the plant's resistance against lepidopteran herbivores. J Chem Ecol. 2011;37:1091–8.CrossRefGoogle Scholar
  15. 15.
    Marzouk MS, El-Toumy SAA, Merfort I, Nawwar MAM. Polyphenolic metabolites of Rhamnusdisperma. Phytochemistry. 1999;52:943–6.CrossRefGoogle Scholar
  16. 16.
    Shaheen F, Ali L, Ali S. ErdemogluN, Sener B. antioxidant flavonoids from Tamus communis ssp. Critica. J Chem Nat Compd. 2009;45:547–972.CrossRefGoogle Scholar
  17. 17.
    Ardhaoui M, Falcimaigne A, Engasser JM, Moussou P, Pauly G, Ghoul M. Acylation of natural flavonoids using lipase of candida antarctica as biocatalyst. J Mol Catal B Enzym. 2004;29:63–7.CrossRefGoogle Scholar
  18. 18.
    Chebil L, Anthoni J, Humeau C, Gerardin C, Engasser JM, Ghoul M. Enzymatic acylation of flavonoids: effect of the nature of the substrate, origin of lipase, and operating conditions on conversion yield and regioselectivity. J Agric Food Chem. 2007;14:9496–502.CrossRefGoogle Scholar
  19. 19.
    Brahemi G, Kona FR, Fiasella A, Buac D, Soukupova J, Brancale A, Burger AM, Westwell AD. Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer. J Med Chem. 2010;53:2757–65.CrossRefGoogle Scholar
  20. 20.
    Rukunga GM, Waterman PG. (1996) Kaempferol glycosides from Albizia versicolor. Bull Chem Soc Ethiop. 1996;10:47–51.Google Scholar
  21. 21.
    Lau CS, Carrier DJ, Beitle RR, Bransby DI, Howard LR, Lay JJO, Liyanage R, Clausen EC. Identification and quantification of glycoside flavonoids in the energy crop Albizia julibrissin. Bioresour Technol. 2007;98:429–35.CrossRefGoogle Scholar
  22. 22.
    Gopiesh KV, Kannabiran K, Rajakumar G, Rahuman AA, Santhoshkumar T. Biolarvicidal compound gymnemagenol isolated from leaf extract of miracle fruit plant, Gymnemasylvestre (Retz) Schult against malaria and filariasis vectors. Parasitol Res. 2011;109:1373–86.CrossRefGoogle Scholar
  23. 23.
    Kraft C, Jenett-Siems K, Siems K, Gupta MP, Bienzle U, Eich E. Antiplasmodial activity of isoflavones from Andirainermis. J Ethnopharmacol. 2000;73:131–5.CrossRefGoogle Scholar
  24. 24.
    Lehane AM, Saliba KJ. Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite. BMC Res Notes. 2008;1:26.CrossRefGoogle Scholar
  25. 25.
    Kuete V, Sandjo LP, Kwamou GMN, Wiench B, Nkengfack AE, Efferth T. Activity of three cytotoxic isoflavonoids from Erythrina excelsa and Erythrina senegalensis (neobavaisoflavone, sigmoidin H and isoneorautenol) toward multi-factorial drug resistant cancer cells. Phytomedecine. 2014;21:682–8.CrossRefGoogle Scholar
  26. 26.
    Li H, Zhang X, Wang W. Anticancer activity of 5,7-dimethoxyflavone against liver cancer cell line HepG2 involves apoptosis, ros generation and cell cycle arrest. Afr J Tradit Complement Altern Med. 2017;14:213–20.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2020

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Romeol Romain Koagne
    • 1
    • 2
  • Frederick Annang
    • 2
  • Bastien Cautain
    • 2
  • Jesús Martín
    • 2
  • Guiomar Pérez-Moreno
    • 3
  • Gabin Thierry M. Bitchagno
    • 1
  • Dolores González-Pacanowska
    • 3
  • Francisca Vicente
    • 2
  • Ingrid Konga Simo
    • 1
    Email author
  • Fernando Reyes
    • 2
  • Pierre Tane
    • 1
    Email author
  1. 1.Department of Chemistry, Faculty of ScienceUniversity of DschangDschangCameroon
  2. 2.Fundación MEDINA, Centro de Excelencia en Investigación de MedicamentosInnovadores en Andalucía, Avda. delConocimiento 34Parque Tecnológico de Ciencias de la SaludGranadaSpain
  3. 3.Instituto de Parasitología y Biomedicina “López-Neyra”Consejo Superior de Investigaciones Científicas (CSIC) Avda. del Conocimiento s/nGranadaSpain

Personalised recommendations